Paul R. Edick
Net Worth

Last updated:

What is Paul R. Edick net worth?

The estimated net worth of Mr. Paul R. Edick is at least $23,291,603 as of 9 Aug 2023. He owns shares worth $16,751,603 as insider and has received compensation worth at least $6,540,000 in Xeris Biopharma Holdings, Inc..

What is the salary of Paul R. Edick?

Mr. Paul R. Edick salary is $1,090,000 per year as Chairman & Chief Executive Officer in Xeris Biopharma Holdings, Inc..

How old is Paul R. Edick?

Mr. Paul R. Edick is 69 years old, born in 1956.

What stocks does Paul R. Edick currently own?

As insider, Mr. Paul R. Edick owns shares in one company:

Company Title Shares Price per share Total value
Xeris Biopharma Holdings, Inc. (XERS) Chairman & Chief Executive Officer 2,288,064 $7.32 $16,751,603

What does Xeris Biopharma Holdings, Inc. do?

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

XERS logo
XERS
Xeris Biopharma Holdings, Inc.
$7.32

Paul R. Edick insider trading

Xeris Biopharma Holdings, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $2.38 $23,790
Purchase
Common Stock 20,000 $1.45 $29,000
Purchase
Common Stock 100,000 $1.4 $140,400
Purchase
Common Stock 20,000 $2.28 $45,660
Purchase
Common Stock 200,000 $2.08 $415,800
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 33,000 N/A N/A
Purchase
Common Stock 20,000 N/A N/A
Purchase
Common Stock 17,935 N/A N/A
Purchase
Common Stock 30,000 N/A N/A

Xeris Biopharma Holdings key executives

Xeris Biopharma Holdings, Inc. executives and other stock owners filed with the SEC: